Stay updated with breaking news from Nasdaq labp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Landos Biopharma, Inc. (NASDAQ:LABP – Free Report) – Stock analysts at Leerink Partnrs issued their Q1 2024 earnings estimates for Landos Biopharma in a research note issued on Monday, February 5th. Leerink Partnrs analyst T. Smith expects that the company will post earnings per share of ($1.12) for the quarter. The consensus estimate for Landos […] ....
Shares of Landos Biopharma, Inc. (NASDAQ:LABP – Get Free Report) shot up 3.5% on Wednesday . The company traded as high as $4.47 and last traded at $4.47. 5,835 shares were traded during trading, a decline of 31% from the average session volume of 8,468 shares. The stock had previously closed at $4.32. Landos Biopharma […] ....
Landos Biopharma, Inc. (NASDAQ:LABP – Get Free Report) saw a large decrease in short interest in the month of October. As of October 31st, there was short interest totalling 14,700 shares, a decrease of 10.9% from the October 15th total of 16,500 shares. Based on an average trading volume of 5,800 shares, the days-to-cover ratio […] ....
Landos Biopharma, Inc. (NASDAQ:LABP – Get Free Report) was the target of a large drop in short interest in October. As of October 31st, there was short interest totalling 14,700 shares, a drop of 10.9% from the October 15th total of 16,500 shares. Currently, 0.5% of the shares of the stock are sold short. Based […] ....
Shares of Landos Biopharma, Inc. (NASDAQ:LABP – Get Free Report) rose 4.3% on Wednesday . The stock traded as high as $3.69 and last traded at $3.69. Approximately 1,274 shares were traded during trading, a decline of 94% from the average daily volume of 22,104 shares. The stock had previously closed at $3.54. Landos Biopharma […] ....